BackgroundInterstitial lung disease (ILD) encompasses diverse pulmonary disorders with varied prognoses. Current pathological diagnoses suffer from inter-observer variability,necessitating more standardized approaches. We developed an ensemble model AI for cryobiopsy, CRAI, an artificial intelligence model to analyze transbronchial lung cryobiopsy (TBLC) specimens and predict patient outcomes. MethodsWe developed an explainable AI model, CRAI, to analyze TBLC. CRAI comprises seven modules for detecting histological features, generating 19 pathologically significant findings. A downstream XGBoost classifier was developed to predict disease progression using these findings. The models performance was evaluated using respiratory function changes and survival analysis in cross-validation and external test cohorts. FindingsIn the internal cross-validation (135 cases), the model predicted 105 cases without disease progression and 30 with disease progression. The annual {Delta}%FVC was -1.293 in the non-progressive group versus -5.198 in the progressive group, outperforming most pathologists diagnoses. In the external test cohort (48 cases), the model predicted 38 non-progressive and 10 progressive cases. Survival analysis demonstrated significantly shorter survival times in the progressive group (p=0.034). InterpretationCRAI provides a comprehensive, interpretable approach to analyzing TBLC specimens, offering potential for standardizing ILD diagnosis and predicting disease progression. The model could facilitate early identification of progressive cases and guide personalized therapeutic interventions. FundingNew Energy and Industrial Technology Development Organization (NEDO) and Japanese Ministry of Health, Labor, and Welfare.

Recent advances in Artificial Intelligence (AI) have started disrupting the healthcare industry, especially medical imaging, and AI devices are increasingly being deployed into clinical practice. Such classifiers have previously demonstrated the ability to discern a range of protected demographic attributes (like race, age, sex) from medical images with unexpectedly high performance, a sensitive task which is difficult even for trained physicians. In this study, we motivate and introduce a general explainable AI (XAI) framework called DREAM (DiscoveRing and Explaining AI Mechanisms) for interpreting how AI models trained on medical images predict protected attributes. Focusing on two modalities, radiology and dermatology, we are successfully able to train high-performing classifiers for predicting race from chest x-rays (ROC-AUC score of [~]0.96) and sex from dermoscopic lesions (ROC-AUC score of [~]0.78). We highlight how incorrect use of these demographic shortcuts can have a detrimental effect on the performance of a clinically relevant downstream task like disease diagnosis under a domain shift. Further, we employ various XAI techniques to identify specific signals which can be leveraged to predict sex. Finally, we propose a technique, which we callremoval via balancing, to quantify how much a signal contributes to the classification performance. Using this technique and the signals identified, we are able to explain [~]15% of the total performance for radiology and [~]42% of the total performance for dermatology. We envision DREAM to be broadly applicable to other modalities and demographic attributes. This analysis not only underscores the importance of cautious AI application in healthcare but also opens avenues for improving the transparency and reliability of AI-driven diagnostic tools.

Lung neuroendocrine tumours (NETs, also known as carcinoids) are rapidly rising in incidence worldwide but have unknown aetiology and limited therapeutic options beyond surgery. We conducted multi-omic analyses on over 300 lung NETs including whole-genome sequencing (WGS), transcriptome profiling, methylation arrays, spatial RNA sequencing, and spatial proteomics. The integration of multi-omic data provides definitive proof of the existence of four strikingly different molecular groups that vary in patient characteristics, genomic and transcriptomic profiles, microenvironment, and morphology, as much as distinct diseases. Among these, we identify a new molecular group, enriched for highly aggressive supra-carcinoids, that displays an immune-rich microenvironment linked to tumour--macrophage crosstalk, and we uncover an undifferentiated cell population within supra-carcinoids, explaining their molecular and behavioural link to high-grade lung neuroendocrine carcinomas. Deep learning models accurately identified the Ca A1, Ca A2, and Ca B groups based on morphology alone, outperforming current histological criteria. The characteristic tumour microenvironment of supra-carcinoids and the validation of a panel of immunohistochemistry markers for the other three molecular groups demonstrates that these groups can be accurately identified based solely on morphological features, facilitating their implementation in the clinical setting. Our proposed morpho-molecular classification highlights group-specific therapeutic opportunities, including DLL3, FGFR, TERT, and BRAF inhibitors. Overall, our findings unify previously proposed molecular classifications and refine the lung cancer map by revealing novel tumour types and potential treatments, with significant implications for prognosis and treatment decision-making.

BackgroundArtificial Intelligence (AI) has evolved through various trends, with different subfields gaining prominence over time. Currently, Conversational Artificial Intelligence (CAI)--particularly Generative AI--is at the forefront. CAI models are primarily focused on text-based tasks and are commonly deployed as chatbots. Recent advancements by OpenAI have enabled the integration of external, independently developed models, allowing chatbots to perform specialized, task-oriented functions beyond general language processing. ObjectiveThis study aims to develop a smart chatbot that integrates large language models (LLMs) from OpenAI with specialized domain-specific models, such as those used in medical image diagnostics. The system leverages transfer learning via Googles Teachable Machine to construct image-based classifiers and incorporates a diabetes detection model developed in TensorFlow.js. A key innovation is the chatbots ability to extract relevant parameters from user input, trigger the appropriate diagnostic model, interpret the output, and deliver responses in natural language. The overarching goal is to demonstrate the potential of combining LLMs with external models to build multimodal, task-oriented conversational agents. MethodsTwo image-based models were developed and integrated into the chatbot system. The first analyzes chest X-rays to detect viral and bacterial pneumonia. The second uses optical coherence tomography (OCT) images to identify ocular conditions such as drusen, choroidal neovascularization (CNV), and diabetic macular edema (DME). Both models were incorporated into the chatbot to enable image-based medical query handling. In addition, a text-based model was constructed to process physiological measurements for diabetes prediction using TensorFlow.js. The architecture is modular: new diagnostic models can be added without redesigning the chatbot, enabling straightforward functional expansion. ResultsThe findings demonstrate effective integration between the chatbot and the diagnostic models, with only minor deviations from expected behavior. Additionally, a stub function was implemented within the chatbot to schedule medical appointments based on the severity of a patients condition, and it was specifically tested with the OCT and X-ray models. ConclusionsThis study demonstrates the feasibility of developing advanced AI systems--including image-based diagnostic models and chatbot integration--by leveraging Artificial Intelligence as a Service (AIaaS). It also underscores the potential of AI to enhance user experiences in bioinformatics, paving the way for more intuitive and accessible interfaces in the field. Looking ahead, the modular nature of the chatbot allows for the integration of additional diagnostic models as the system evolves.

Recent advances in vision-language models (VLMs) have enabled automatic radiology report generation, yet current evaluation methods remain limited to general-purpose NLP metrics or coarse classification-based clinical scores. In this study, we propose a clinically informed evaluation framework for VLM-generated radiology reports that goes beyond traditional performance measures. We define a taxonomy of 12 radiology-specific error types, each annotated with clinical risk levels (low, medium, high) in collaboration with physicians. Using this framework, we conduct a comprehensive error analysis of three representative VLMs, i.e., DeepSeek VL2, CXR-LLaVA, and CheXagent, on 685 gold-standard, expert-annotated MIMIC-CXR cases. We further introduce a risk-aware evaluation metric, the Clinical Risk-weighted Error Score for Text-generation (CREST), to quantify safety impact. Our findings reveal critical model vulnerabilities, common error patterns, and condition-specific risk profiles, offering actionable insights for model development and deployment. This work establishes a safety-centric foundation for evaluating and improving medical report generation models. The source code of our evaluation framework, including CREST computation and error taxonomy analysis, is available at https://github.com/guanharry/VLM-CREST.

Pneumonia is a respiratory condition characterized by inflammation of the alveolar sacs in the lungs, which disrupts normal oxygen exchange. This disease disproportionately impacts vulnerable populations, including young children (under five years of age) and elderly individuals (over 65 years), primarily due to their compromised immune systems. The mortality rate associated with pneumonia remains alarmingly high, particularly in low-resource settings where healthcare access is limited. Although effective prevention strategies exist, pneumonia continues to claim the lives of approximately one million children each year, earning its reputation as a "silent killer." Globally, an estimated 500 million cases are documented annually, underscoring its widespread public health burden. This study explores the design and evaluation of the CNN-based Computer-Aided Diagnostic (CAD) systems with an aim of carrying out competent as well as resourceful classification and categorization of chest radiographs into binary classes (Normal, Pneumonia). An augmented Kaggle dataset of 18,200 chest radiographs, split between normal and pneumonia cases, was utilized. This study conducts a series of experiments to evaluate lightweight CNN models--ShuffleNet, NASNet-Mobile, and EfficientNet-b0--using transfer learning that achieved accuracy of 90%, 88% and 89%, prompting the task for deep feature extraction from each of the networks and applying feature fusion to further pair it with SVM classifier and XGBoost classifier, achieving an accuracy of 97% and 98% resepectively. The proposed research emphasizes the crucial role of CAD systems in advancing radiological diagnostics, delivering effective solutions to aid radiologists in distinguishing between diagnoses by applying feature fusion, feature selection along with various machine learning algorithms and deep learning architectures.

The ToolCAP cohort study is a prospective, observational, multi-site platform study designed to collect harmonized, high-quality clinical, imaging, and biological data on children with IMCI-defined pneumonia in low- and middle-income countries (LMICs). The primary objective is to inform the development and validation of diagnostic and prognostic tools, including lung ultrasound (LUS), point-of-care biomarkers, and AI-based models, to improve pneumonia diagnosis, management, and antimicrobial stewardship. This statistical analysis plan (SAP) outlines the analytic strategy for describing the study population, assessing the performance of candidate diagnostic tools, and enabling data sharing in support of secondary research questions and AI model development. Children under 12 years presenting with suspected pneumonia are enrolled within 24 hours of presentation and undergo clinical assessment, digital auscultation, LUS, and optional biological sampling. Follow-up occurs on Day 8 and Day 29 to assess outcomes including recovery, treatment response, and complications. The SAP details variable definitions, data management strategies, and pre-specified analyses, including descriptive summaries, sensitivity and specificity of diagnostic tools against clinical reference standards, and exploratory subgroup analyses.

Lung cancer remains one of the leading causes of cancer mortality, and while low dose CT screening improves mortality, radiological detection is challenging due to the increasing shortage of radiologists. Artificial intelligence can significantly improve the procedure and also decrease the overall workload of the entire healthcare department. Building upon the existing works of application of genetic algorithm this study aims to create a novel algorithm for lung cancer diagnosis with utmost precision. We included a total of 156 CT scans of patients divided into two databases, followed by feature extraction using image statistics, histograms, and 2D transforms (FFT, DCT, WHT). Optimal feature vectors were formed and organized into Excel based knowledge-bases. Genetically trained classifiers like MLP, GFF-NN, MNN and SVM, are then optimized, with experimentations with different combinations of parameters, activation functions, and data partitioning percentages. Evaluation metrics included classification accuracy, Mean Squared Error (MSE), Area under Receiver Operating Characteristics (ROC) curve, and computational efficiency. Computer simulations demonstrated that the MNN (Topology II) classifier, specifically when trained with FFT coefficients and a momentum learning rule, consistently achieved 100% average classification accuracy on the cross-validation dataset for both Data-base I and Data-base II, outperforming MLP-based classifiers. This genetically optimized and trained MNN (Topology II) classifier is therefore recommended as the optimal solution for lung cancer diagnosis from CT scan images.

Fetal MRI is increasingly being employed in the diagnosis of fetal lung anomalies and segmentation-derived total fetal lung volumes are used as one of the parameters for prediction of neonatal outcomes. However, in clinical practice, segmentation is performed manually in 2D motion-corrupted stacks with thick slices which is time consuming and can lead to variations in estimated volumes. Furthermore, there is a known lack of consensus regarding a universal lung parcellation protocol and expected normal total lung volume formulas. The lungs are also segmented as one label without parcellation into lobes. In terms of automation, to the best of our knowledge, there have been no reported works on multi-lobe segmentation for fetal lung MRI. This work introduces the first automated deep learning segmentation pipeline for multi-regional lung segmentation for 3D motion-corrected T2w fetal body images for normal anatomy and congenital diaphragmatic hernia cases. The protocol for parcellation into 5 standard lobes was defined in the population-averaged 3D atlas. It was then used to generate a multi-label training dataset including 104 normal anatomy controls and 45 congenital diaphragmatic hernia cases from 0.55T, 1.5T and 3T acquisition protocols. The performance of 3D Attention UNet network was evaluated on 18 cases and showed good results for normal lung anatomy with expectedly lower Dice values for the ipsilateral lung. In addition, we also produced normal lung volumetry growth charts from 290 0.55T and 3T controls. This is the first step towards automated multi-regional fetal lung analysis for 3D fetal MRI.

BackgroundComputer-aided detection (CAD) software analyzes chest X-rays for features suggestive of tuberculosis (TB) and provides a numeric abnormality score. However, estimates of CAD accuracy for TB screening are hindered by the lack of confirmatory data among people with lower CAD scores, including those without symptoms. Additionally, the appropriate CAD score thresholds for obtaining further testing may vary according to population and client characteristics. MethodsWe screened for TB in Ugandan individuals aged [&ge;]15 years using portable chest X-rays with CAD (qXR v3). Participants were offered screening regardless of their symptoms. Those with X-ray scores above a threshold of 0.1 (range, 0 - 1) were asked to provide sputum for Xpert Ultra testing. We estimated the diagnostic accuracy of CAD for detecting Xpert-positive TB when using the same threshold for all individuals (under different assumptions about TB prevalence among people with X-ray scores <0.1), and compared this estimate to age- and/or sex-stratified approaches. FindingsOf 52,835 participants screened for TB using CAD, 8,949 (16.9%) had X-ray scores [&ge;]0.1. Of 7,219 participants with valid Xpert Ultra results, 382 (5.3%) were Xpert-positive, including 81 with trace results. Assuming 0.1% of participants with X-ray scores <0.1 would have been Xpert-positive if tested, qXR had an estimated AUC of 0.920 (95% confidence interval 0.898-0.941) for Xpert-positive TB. Stratifying CAD thresholds according to age and sex improved accuracy; for example, at 96.1% specificity, estimated sensitivity was 75.0% for a universal threshold (of [&ge;]0.65) versus 76.9% for thresholds stratified by age and sex (p=0.046). InterpretationThe accuracy of CAD for TB screening among all screening participants, including those without symptoms or abnormal chest X-rays, is higher than previously estimated. Stratifying CAD thresholds based on client characteristics such as age and sex could further improve accuracy, enabling a more effective and personalized approach to TB screening. FundingNational Institutes of Health Research in contextO_ST_ABSEvidence before this studyC_ST_ABSThe World Health Organization (WHO) has endorsed computer-aided detection (CAD) as a screening tool for tuberculosis (TB), but the appropriate CAD score that triggers further diagnostic evaluation for tuberculosis varies by population. The WHO recommends determining the appropriate CAD threshold for specific settings and population and considering unique thresholds for specific populations, including older age groups, among whom CAD may perform poorly. We performed a PubMed literature search for articles published until September 9, 2024, using the search terms "tuberculosis" AND ("computer-aided detection" OR "computer aided detection" OR "CAD" OR "computer-aided reading" OR "computer aided reading" OR "artificial intelligence"), which resulted in 704 articles. Among them, we identified studies that evaluated the performance of CAD for tuberculosis screening and additionally reviewed relevant references. Most prior studies reported area under the curves (AUC) ranging from 0.76 to 0.88 but limited their evaluations to individuals with symptoms or abnormal chest X-rays. Some prior studies identified subgroups (including older individuals and people with prior TB) among whom CAD had lower-than-average AUCs, and authors discussed how the prevalence of such characteristics could affect the optimal value of a population-wide CAD threshold; however, none estimated the accuracy that could be gained with adjusting CAD thresholds between individuals based on personal characteristics. Added value of this studyIn this study, all consenting individuals in a high-prevalence setting were offered chest X-ray screening, regardless of symptoms, if they were [&ge;]15 years old, not pregnant, and not on TB treatment. A very low CAD score cutoff (qXR v3 score of 0.1 on a 0-1 scale) was used to select individuals for confirmatory sputum molecular testing, enabling the detection of radiographically mild forms of TB and facilitating comparisons of diagnostic accuracy at different CAD thresholds. With this more expansive, symptom-neutral evaluation of CAD, we estimated an AUC of 0.920, and we found that the qXR v3 threshold needed to decrease to under 0.1 to meet the WHO target product profile goal of [&ge;]90% sensitivity and [&ge;]70% specificity. Compared to using the same thresholds for all participants, adjusting CAD thresholds by age and sex strata resulted in a 1 to 2% increase in sensitivity without affecting specificity. Implications of all the available evidenceTo obtain high sensitivity with CAD screening in high-prevalence settings, low score thresholds may be needed. However, countries with a high burden of TB often do not have sufficient resources to test all individuals above a low threshold. In such settings, adjusting CAD thresholds based on individual characteristics associated with TB prevalence (e.g., male sex) and those associated with false-positive X-ray results (e.g., old age) can potentially improve the efficiency of TB screening programs.